We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Hemostasis Analyzer Provides Clotting, Chromogenic, and Immunoturbidimetric Testing Capabilities

By Labmedica staff writers
Posted on 06 Aug 2008
A powerful hemostasis analyzer has been developed for mid-high volume laboratories.

Called the ACL TOP 500 CTS (closed tube sampling) hemostasis analyzer, it is the newest addition to the family of ACL TOP systems, and was released by Beckman Coulter (Fullerton, CA, USA) in partnership with Instrument Laboratory (IL; Huntington Beach, CA, USA). More...


The hemostasis analyzer offers 24-hour, 7-day continuous operation without workflow interruption. It can hold 800 cuvettes and delivers up to 240 tests per hour. Cap piercing is automated and results arrive quickly, with prothrombin time (PT) reported in three minutes or less.

The analyzer provides clotting, chromogenic and immunoturbidimetric testing capabilities with a complete menu of routine and specialty assays. Its LED-based clot detection allows it to read clot-based assays at 671 nm, which helps minimize the effects of most preanalytic variables. The interface is user-friendly and operators need only a minimal amount of training.

The TOP 500 CTS is a compact, powerful analyzer that helps labs maximize labor resources, reduce turnaround time, and improve patient care.

Beckman Coulter provides a wide range of coagulation analyzers that deliver consistent, quality results with minimal maintenance. The wide selection of specialty assays and reagents are also designed to maximize the labs' capabilities. The company also offers service to enable the labs to operate at peak efficiency.


Related Links:
Beckman Coulter

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Steam Sterilizer
Hi Vac II Line
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.